Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| On Ternary Complex Stability in Protein Degradation: In Silico Molecular Glue Binding Affinity Calculations. | J Chem Inf Model | 2023 | 37037192 | PubTator, text mining | PubMed |
| Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic Fusions. | J Med Chem | 2023 | 37036171 | PubTator, text mining | PubMed |
| DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells. | Nat Cell Biol | 2023 | 37024683 | PubTator, text mining | PubMed |
| Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents. | RSC Adv | 2023 | 37021105 | PubTator, text mining | PubMed |
| An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC). | J Hepatocell Carcinoma | 2023 | 37020465 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles. | Bioorg Med Chem | 2023 | 37018877 | PubTator, text mining | PubMed |
| Recommendations on the use of azole antifungals in hematology-oncology patients. | Rev Esp Quimioter | 2023 | 37017117 | PubTator, text mining | PubMed |
| ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas. | Cell Chem Biol | 2023 | 37015223 | PubTator, text mining | PubMed |
| Advances in the potential roles of Cullin-RING ligases in regulating autoimmune diseases. | Front Immunol | 2023 | 37006236 | PubTator, text mining | PubMed |
| Phase separation in cancer at a glance. | J Transl Med | 2023 | 37005672 | PubTator, text mining | PubMed |
| Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy. | Exp Hematol Oncol | 2023 | 36998063 | PubTator, text mining | PubMed |
| The stem cell-supporting small molecule UM171 triggers Cul3-KBTBD4-mediated degradation of ELM2 domain-harboring proteins. | J Biol Chem | 2023 | 36997086 | PubTator, text mining | PubMed |
| Heterobifunctional Ligase Recruiters Enable pan-Degradation of Inhibitor of Apoptosis Proteins. | J Med Chem | 2023 | 36996313 | PubTator, text mining | PubMed |
| PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy. | Mol Cancer | 2023 | 36991452 | PubTator, text mining | PubMed |
| Corrigendum to "Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation" [Eur. J. Med. Chem. 223 (2021) 11-05 113645]. | Eur J Med Chem | 2023 | 36989810 | PubTator, text mining | PubMed |
| 2-Aminobenzothiazoles in anticancer drug design and discovery. | Bioorg Chem | 2023 | 36989736 | PubTator, text mining | PubMed |
| Cereblon-Recruiting PROTACs: Will New Drugs Have to Face Old Challenges? | Pharmaceutics | 2023 | 36986673 | PubTator, text mining | PubMed |
| Current Status of Oligonucleotide-Based Protein Degraders. | Pharmaceutics | 2023 | 36986626 | PubTator, text mining | PubMed |
| Past, Present, and a Glance into the Future of Multiple Myeloma Treatment. | Pharmaceuticals (Basel) | 2023 | 36986514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=39